Apple countersues Qualcomm, alleging that Snapdragon chips, which power a variety of Android devices, infringe on Apple's patents
(Reuters) - Apple Inc on Wednesday filed a countersuit against Qualcomm Inc, alleging that Qualcomm's Snapdragon mobile phone chips that power a wide variety …
Context & Ripple Effects
This countersuit is Apple's latest escalation in a legal war that began when it stopped paying royalties and accused Qualcomm of an illegal business model. Qualcomm answered with its own countersuit in April, then broadened the fight by suing Apple's contract manufacturers Compal, Foxconn, Pegatron, and Wistron over unpaid royalties.
By turning its patents against Snapdragon itself, Apple is attacking the revenue engine behind Qualcomm's chip business rather than just its licensing terms — a shift from a payment dispute to mutual patent warfare.
First-order effects
- Qualcomm must now defend its flagship Snapdragon line against infringement claims, putting its core chip business — not just its licensing arm — at legal risk.
- Android device makers that ship Snapdragon chips become indirect targets, since Apple's claims attach to the silicon inside their products.
Second-order effects
- Qualcomm's counter-strategy of suing Apple's suppliers and seeking sales bans pressures the contract manufacturers, who now sit between two customers fighting over royalties they pay.
- Android OEMs gain leverage in their own chip negotiations, since every new Apple claim weakens Qualcomm's position that its patents are untouchable.
Third-order effects
- If both sides keep winning partial victories across jurisdictions, handset patent enforcement drifts toward mutually assured litigation, raising the odds of a negotiated global settlement or a structural split between chip supply and licensing.
- The dispute tests whether a component supplier can charge royalties on the whole device — a model whose survival shapes pricing across the entire smartphone industry.
The trend: The Apple-Qualcomm fight is evolving from a royalty dispute into multi-front patent warfare spanning US courts, Chinese courts, and trade regulators, with device makers and suppliers caught in between.